-
161
Dose-dependent response to long-term clomiphene citrate in male functional hypogonadotropic hypogonadism
Published 2023-02-01Get full text
Article -
162
-
163
Metabolite signatures of heart failure, sleep apnoea, their interaction, and outcomes in the community
Published 2021-12-01Get full text
Article -
164
-
165
-
166
Long-term outcomes of patients with single ventricle who do not undergo Fontan palliation
Published 2023-06-01Get full text
Article -
167
An uncommon bone tumor in an even more uncommon location: A case of cuboid osteoid osteoma
Published 2022-01-01Get full text
Article -
168
-
169
-
170
-
171
-
172
-
173
-
174
-
175
Accelerated forgetting of contextual details due to focal medio-dorsal thalamic lesion
Published 2014-09-01Get full text
Article -
176
-
177
Management of obesity and cardiometabolic risk – role of phentermine/extended release topiramate
Published 2014-02-01“…Arianne N Sweeting,1 Eddy Tabet,1 Ian D Caterson,1,2 Tania P Markovic1,2 1Department of Endocrinology, Royal Prince Alfred Hospital, Sydney, NSW, Australia; 2Boden Institute of Obesity, Nutrition, Exercise & Eating Disorders, University of Sydney, NSW, Australia Abstract: The US Food and Drug Administration (FDA) recently approved lorcaserin and the combination of phentermine and extended release topiramate (phentermine/topiramate ER) for the treatment of obesity in conjunction with a lifestyle intervention, expanding the therapeutic options for long-term obesity pharmacotherapy, which was previously limited to orlistat. …”
Get full text
Article -
178
Neuronal connected burst cascades bridge macroscale adaptive signatures across arousal states
Published 2023-10-01Get full text
Article -
179
-
180